I agree that this site is using cookies. You can find further informations here.
X
Gever, Joel
64  results:
Search for persons X
?
1

P2X3 receptor antagonism reduces the occurrence of apnoeas ..:

Katayama, Pedro Lourenço ; Abdala, Ana Paula ; Charles, Ian...
Respiratory Physiology & Neurobiology.  277 (2020)  - p. 103438 , 2020
Link: https://doi.org/10.1016/..
 
?
2

2-Aminothiazoles as Therapeutic Leads for Prion Diseases:

Gallardo-Godoy, Alejandra ; Gever, Joel ; Fife, Kimberly L....
Journal of Medicinal Chemistry.  54 (2011)  4 - p. 1010-1021 , 2011
Link: https://doi.org/10.1021/..
 
?
3

Discovery of 6-substituted indole-3-glyoxylamides as lead a..:

Thompson, Mark J. ; Louth, Jennifer C. ; Ferrara, Steven...
European Journal of Medicinal Chemistry.  46 (2011)  9 - p. 4125-4132 , 2011
Link: https://doi.org/10.1016/..
 
?
4

Electrophysiological determination of antagonist mechanism ..:

Panicker, Sandip ; Henningsen, Robert ; Soto, Rothschild...
The FASEB Journal.  22 (2008)  S2 - p. 626-626 , 2008
Link: https://doi.org/10.1096/..
 
?
5

RO1138452 and RO3244794: characterization of structurally d..:

Bley, Keith R ; Bhattacharya, Anindya ; Daniels, Don V...
British Journal of Pharmacology.  147 (2006)  3 - p. 335-345 , 2006
Link: https://doi.org/10.1038/..
 
?
6

Developmental changes in heteromeric P2X2/3receptor express..:

Dunn, Philip M. ; Gever, Joel ; Ruan, Huai-Zhen.
Developmental Dynamics.  234 (2005)  3 - p. 505-511 , 2005
Link: https://doi.org/10.1002/..
 
?
7

Fingerprinting heterocellular β-adrenoceptor functional exp..:

Matt, Rachel A. ; Westhorpe, Frederick G. ; Romuar, Rosemary F....
Frontiers in Molecular Biosciences.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

The discovery and development of gefapixant:

Ford, Anthony P. ; Dillon, Michael P. ; Kitt, Michael M..
Autonomic Neuroscience.  235 (2021)  - p. 102859 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Action of MK‐7264 (gefapixant) at human P2X3 and P2X2/3 rec..:

Richards, David ; Gever, Joel R. ; Ford, Anthony P..
British Journal of Pharmacology.  176 (2019)  13 - p. 2279-2291 , 2019
Link: https://doi.org/10.1111/..
 
?
10

Novel compounds lowering the cellular isoform of the human ..:

Silber, B. Michael ; Gever, Joel R. ; Rao, Satish...
Bioorganic & Medicinal Chemistry.  22 (2014)  6 - p. 1960-1972 , 2014
Link: https://doi.org/10.1016/..
 
?
11

Towards Optimization of Arylamides As Novel, Potent, and Br..:

Li, Zhe ; Rao, Satish ; Gever, Joel R....
ACS Medicinal Chemistry Letters.  4 (2013)  7 - p. 647-650 , 2013
Link: https://doi.org/10.1021/..
 
?
12

Discovery and Preliminary Structure–Activity Relationship o..:

Li, Zhe ; Gever, Joel R. ; Rao, Satish...
ACS Medicinal Chemistry Letters.  4 (2013)  4 - p. 397-401 , 2013
Link: https://doi.org/10.1021/..
 
?
13

Pharmacokinetics and Metabolism of 2-Aminothiazoles with An..:

Silber, B. Michael ; Rao, Satish ; Fife, Kimberly L....
Pharmaceutical Research.  30 (2013)  4 - p. 932-950 , 2013
Link: https://doi.org/10.1007/..
 
?
14

Antiprion compounds that reduce PrPSc levels in dividing an..:

Silber, B. Michael ; Gever, Joel R. ; Li, Zhe...
Bioorganic & Medicinal Chemistry.  21 (2013)  24 - p. 7999-8012 , 2013
Link: https://doi.org/10.1016/..
 
?
15

2‐Aminothiazoles with Improved Pharmacotherapeutic Properti..:

Li, Zhe ; Silber, B. Michael ; Rao, Satish...
ChemMedChem.  8 (2013)  5 - p. 847-857 , 2013
Link: https://doi.org/10.1002/..
 
1-15